News
News from us and our partners
Tags
Topics
0 results
- News
Neurent Medical raises €62.5M Series C to expand NEUROMARK
- News
First patient treated in GenSight's LUMEVOQ REVISE study
- News
Biotalys refocuses strategy to prioritise lead biocontrol assets
- News
Cure51 appoints Ashley Lakner as chief scientific officer
- News
BrightHeart Announces Voluson™ Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam
- News
Mainstay Medical wins Blue Cross Blue Shield coverage for ReActiv8
- News
NodThera appoints Geoff McDonough as CEO
- News
FDA approves Tenpoint's YUVEZZI for presbyopia
- News
nChroma Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of Epigenetic Silencer CRMA-1001 for Chronic Hepatitis B
- News
Tenpoint Therapeutics raises $235M to launch YUVEZZI
- News
Sensorion raises €60M with €20M strategic investment from Sanofi
- News
Sitryx doses first atopic dermatitis patients with SYX-5219
- News
HighLife receives CE Mark for its TMVR system
- News
Genespire wins FDA and EC orphan drug designation for GENE202
- News
SafeHeal launches SAFE-3CV IDE study for Colovac device